Biosensors for detecting biomarkers and methods of fabricating and using the same

US12130286B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12130286-B2
Application numberUS-202217806109-A
CountryUS
Kind codeB2
Filing dateJun 9, 2022
Priority dateJun 9, 2022
Publication dateOct 29, 2024
Grant dateOct 29, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Biosensors capable of detecting certain biomarkers (e.g., platelet-derived growth factor-BB (PDGF-BB)), as well as methods of fabricating the same and methods of using the same, are provided. The biosensors can be disposable and/or label-free. Electrochemical bipolar exfoliation can be used to exfoliate, reduce, and deposit (in a single step) graphene nanosheets on a desired substrate (e.g., an electrode). Affinity aptamers can be immobilized on the graphene nanosheets disposed on the substrate.

First claim

Opening claim text (preview).

What is claimed is: 1. A biosensor for detecting a biomarker, the biosensor comprising: an electrode comprising a metal; reduced graphene oxide (rGO) disposed on the electrode, the rGO comprising graphene nanosheets; and a plurality of aptamers disposed on the rGO, the plurality of aptamers being configured to bind to the biomarker, the plurality of aptamers being directly immobilized on the graphene nanosheets without any mediator or linking layer disposed therebetween, the rGO covering at least 90% of an upper surface of the metal of the electrode, and the rGO having a vertically aligned structure. 2. The biosensor according to claim 1 , the electrode further comprising a substrate on which the metal is disposed. 3. The biosensor according to claim 2 , the substrate being a polymer. 4. The biosensor according to claim 3 , the substrate being polyethylene terephthalate (PET). 5. The biosensor according to claim 1 , the metal being gold (Au). 6. The biosensor according to claim 1 , the metal being stainless steel (SS). 7. The biosensor according to claim 1 , the biomarker being a cancer biomarker. 8. The biosensor according to claim 1 , the biomarker being platelet-derived growth factor-BB (PDGF-BB). 9. The biosensor according to claim 1 , the biosensor being label-free. 10. The biosensor according to claim 1 , the biosensor being disposable. 11. The biosensor according to claim 1 , the biosensor having a lower limit of detection for the biomarker of less than 1 picomolar (pM). 12. A biosensor for detecting a biomarker, the biosensor comprising: an electrode comprising a metal; reduced graphene oxide (rGO) disposed on the electrode, the rGO comprising graphene nanosheets; and a plurality of aptamers disposed on the rGO, the plurality of aptamers being configured to bind to the biomarker, the biomarker being platelet-derived growth factor-BB (PDGF-BB), the rGO covering at least 90% of an upper surface of the metal of the electrode, the rGO having a vertically aligned structure, the biosensor being label-free, the biosensor being disposable, the biosensor having a lower limit of detection for the biomarker of less than 1 picomolar (pM), the plurality of aptamers being directly immobilized on the graphene nanosheets without any mediator or linking layer disposed therebetween, and the electrode comprising either feature a) or feature b): a) the electrode comprising a substrate on which the metal is disposed, the metal being gold (Au), and the substrate being polyethylene terephthalate (PET); or b) the metal of the electrode being stainless steel (SS).

Assignees

Inventors

Classifications

  • involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites · CPC title

  • Platelet-derived growth factor [PDGF] · CPC title

  • being a hybridisation with immobilised receptors (using a FET type sensor G01N27/4145; concerning the hybridisation C12Q1/68) · CPC title

  • at least partially made of carbon · CPC title

  • Electrodes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12130286B2 cover?
Biosensors capable of detecting certain biomarkers (e.g., platelet-derived growth factor-BB (PDGF-BB)), as well as methods of fabricating the same and methods of using the same, are provided. The biosensors can be disposable and/or label-free. Electrochemical bipolar exfoliation can be used to exfoliate, reduce, and deposit (in a single step) graphene nanosheets on a desired substrate (e.g., an…
Who is the assignee on this patent?
Forouzanfar Shahrzad, Khakpour Iman, Pala Nezih, and 2 more
What technology area does this patent fall under?
Primary CPC classification G01N33/5758. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).